Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 264Glioma 109Brain Neoplasms 104Gliosarcoma 85Central Nervous System Neoplasms 64Astrocytoma 61Melanoma 46Oligodendroglioma 44Neuroblastoma 28Recurrence 22Neoplasm Metastasis 18Neoplasms 16Medulloblastoma 16Ependymoma 16Sarcoma, Ewing 13Lymphoma 13Sarcoma 12Rhabdomyosarcoma 11Neuroendocrine Tumors 11Lung Neoplasms 11Diffuse Intrinsic Pontine Glioma 10Small Cell Lung Carcinoma 9Neuroectodermal Tumors, Primitive 7Colorectal Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 6Osteosarcoma 6Pinealoma 5Optic Nerve Glioma 5Choroid Plexus Neoplasms 5Carcinoma, Non-Small-Cell Lung 5

Interventions

Carboplatin 10Paclitaxel 5Nivolumab 4Pemetrexed 3Cisplatin 3atezolizumab 2apatinib 2Surveys and Questionnaires 2One-Lung Ventilation 2Ipilimumab 2Blood Specimen Collection 2Bevacizumab 2zimberelimab 1toripalimab 1spartalizumab 1sitravatinib 1sintilimab 1sacituzumab govitecan 1pembrolizumab 1lorlatinib 1cemiplimab 1camrelizumab 1Vital Signs 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Tomography, Emission-Computed, Single-Photon 1Temozolomide 1Telescopes 1Talc 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Diseases × Temozolomide × Clear all
NCT00249964 2016-01-20

Combination Paclitaxel, Carboplatin and Temozolomide

New Mexico Cancer Research Alliance

Phase 1 Completed
15 enrolled

Lung Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡